Descriptive epidemiology of selected congenital heart defects, Hawaii, 1986-1999

Mathias B Forrester1, Ruth D Merz

  • 1Hawaii Birth Defects Program, Honolulu, HI 96817-5157, USA.

Insights

Demographic factors influence congenital heart defect rates. Maternal age and race/ethnicity were linked to specific heart defects, with some variations noted compared to existing literature.

Area of Science:

  • Cardiovascular Research
  • Pediatric Cardiology
  • Birth Defects Epidemiology

Background:

  • Congenital heart defects (CHDs) are the leading cause of infant mortality from birth defects.
  • Understanding demographic influences on CHDs is crucial for public health initiatives.

Purpose of the Study:

  • To investigate the association between demographic factors and specific CHDs in Hawaii's multiethnic population.
  • To identify trends in CHD occurrence over time and by demographic variables.

Main Methods:

  • Utilized a population-based birth defects registry in Hawaii (1986-1999).
  • Analyzed CHD rates in relation to maternal age, race/ethnicity, and sex.
  • Compared incidence rates between two time periods (1986-1992 and 1993-1999).

Main Results:

  • Increased rates for transposition of the great arteries and Ebstein's anomaly; decreased rates for tetralogy of Fallot.
  • Elevated CHD rates (ventricular septal defect, atrial septal defect, etc.) associated with maternal age ≥35 years, even after excluding chromosomal abnormalities.
  • Significant racial/ethnic and sex-based disparities observed for various CHDs, with some findings aligning with and others diverging from existing literature.

Conclusions:

  • Maternal age, race/ethnicity, and sex are significant demographic factors associated with specific congenital heart defects.
  • Temporal trends and demographic associations for certain CHDs warrant further investigation.
  • Findings highlight the need for tailored public health strategies considering diverse populations and specific defect types.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...